Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer
Crossref DOI link: https://doi.org/10.1186/s12906-017-1971-1
Published Online: 2017-09-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huber, Roman
Schlodder, Dietrich
Effertz, Carola
Rieger, Sabine
Tröger, Wilfried
Funding for this research was provided by:
Helixor Heilmittel
